Proteome analysis reveals disease-associated marker proteins to differentiate RA patients from other inflammatory joint diseases with the potential to monitor anti-TNFalpha therapy

Pathology, Research and Practice
Susanne DryndaJörn Kekow

Abstract

New experimental approaches of molecular medicine such as transcriptome and proteome analysis have been implemented in rheumatology research. Two-dimensional gel electrophoresis in combination with mass spectrometry was used to visualize and to identify proteins in synovial fluid (SF) and plasma samples from patients with rheumatoid arthritis (RA) and osteoarthritis (OA). The small calcium binding protein S100A9 (MRP14) was identified as a discriminatory marker protein in SF by global proteomic analysis. To confirm these results and to examine the reproducibility and the applicability as a diagnostic marker, levels of the S100A8 (MRP8)/A9 (MRP14) heterocomplex in plasma and in synovial fluid were validated from patients with RA, OA, and other inflammatory joint diseases using enzyme immunoassay techniques. It was found that plasma levels of the S100A8/A9 heterocomplex correlate well with levels in SF, and hence, determination of plasma levels can be used to distinguish RA patients from patients with other inflammatory joint diseases, as well as from OA patients and controls. Initial studies on RA patients also indicate that plasma levels of the S100A8/A9 heterocomplex are a useful marker in monitoring anti TNFalpha therapy.

References

Mar 18, 1997·Proceedings of the National Academy of Sciences of the United States of America·R A HellerR W Davis
Mar 1, 1997·Electrophoresis·L Anderson, J Seilhamer
Jan 27, 1999·Biochimica Et Biophysica Acta·C KerkhoffC Sorg
Sep 29, 2001·Molecular Pathology : MP·B Isaksen, M K Fagerhol
Jul 16, 2002·Annual Review of Biomedical Engineering·Martin L Yarmush, Arul Jayaraman
Sep 18, 2003·Arthritis and Rheumatism·Michael FroschJohannes Roth
Jan 8, 2004·Clinical Chemistry and Laboratory Medicine : CCLM·Peter LorenzMichael O Glocker

❮ Previous
Next ❯

Citations

Jul 20, 2007·Pharmacogenomics·Marieke J H CoenenBarbara Franke
Mar 12, 2005·Current Rheumatology Reports·Carol A Feghali-Bostwick
Jul 5, 2006·Arthritis Research & Therapy·Thierry LequerréJean-Philippe Salier
Feb 3, 2009·Rheumatology International·Antoaneta TonchevaNina Ivanovska
Jun 2, 2009·Rheumatology·Carine BansardXavier Le-Loët
Dec 11, 2007·Expert Review of Proteomics·Laura GiustiAntonio Lucacchini
Dec 18, 2008·Expert Review of Proteomics·Kelly Tilleman, Dieter Deforce
Nov 1, 2006·Expert Opinion on Drug Discovery·Stijn LambrechtDirk Elewaut
Aug 10, 2011·Wiley Interdisciplinary Reviews. Systems Biology and Medicine·Alexander Y HuiRobert L Sah
Jun 5, 2016·Journal of Trace Elements in Medicine and Biology : Organ of the Society for Minerals and Trace Elements (GMS)·Mario F MoyanoRaúl A Gil
Jun 14, 2013·Critical Reviews in Clinical Laboratory Sciences·Daniela CretuVinod Chandran
Apr 5, 2016·Expert Review of Molecular Diagnostics·Ana MárquezF David Carmona
Nov 30, 2016·Experimental Biology and Medicine·Francesca OmettoAndrea Doria
Jun 1, 2007·Autoimmunity Reviews·Danilo VillaltaNicola Bizzaro
Jun 14, 2005·Molecular & Cellular Proteomics : MCP·Jiang WuMary Jane Thomassen
Jun 3, 2005·Nature·C Garrison FathmanPaul J Utz
Dec 6, 2017·Critical Reviews in Clinical Laboratory Sciences·Shalini M MahendranVinod Chandran
Nov 27, 2009·European Journal of Mass Spectrometry·R F El-KasedM O Glocker
Apr 17, 2009·The Journal of Rheumatology·Xiaotian ChangJinxiang Han
Mar 3, 2015·The Journal of Rheumatology·Mads AbildtrupDavid L Scott
Nov 4, 2006·Proteomics·Shen HuDavid T Wong
May 3, 2007·Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society·Marla J SteinbeckJavad Parvizi
Aug 1, 2007·Proteomics. Clinical Applications·David S Gibson, Madeleine E Rooney
Mar 1, 2008·Proteomics. Clinical Applications·Stijn LambrechtDieter Deforce
Feb 1, 2008·Proteomics. Clinical Applications·Richard Wilson, John F Bateman
Feb 18, 2009·Clinical and Experimental Immunology·S FabreC Jorgensen
Feb 1, 2009·Proteomics. Clinical Applications·Emilio CamafeitaBenjamín Fernández-Gutiérrez
Aug 30, 2005·Annals of the New York Academy of Sciences·Stanley M Naguwa
Nov 12, 2005·Medicinal Research Reviews·Michael O GlockerHans-Jürgen Thiesen
Jan 24, 2007·Microbiology and Immunology·Sonoko ShimadaTomohiro Kato
Apr 19, 2018·Expert Review of Clinical Immunology·Stephanie LingAnne Barton
Jun 2, 2005·Rheumatology·K TillemanD Elewaut
Jun 11, 2017·Clinical Rheumatology·Xi XieJian Chen
Aug 12, 2005·Current Opinion in Rheumatology·Virginia Byers Kraus
Apr 21, 2017·Expert Review of Proteomics·Lucía LouridoCristina Ruiz-Romero
Jul 15, 2015·Expert Review of Proteomics·Cristina Ruiz-RomeroFrancisco J Blanco

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.